159 related articles for article (PubMed ID: 20334650)
1. Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas.
Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y
J Exp Clin Cancer Res; 2010 Mar; 29(1):26. PubMed ID: 20334650
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of WIF-1 by hypermethylation in astrocytomas.
Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y; Song T; Zeng F; Rao Y
Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):418-25. PubMed ID: 20539942
[TBL] [Abstract][Full Text] [Related]
3. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.
Ding Z; Qian YB; Zhu LX; Xiong QR
World J Gastroenterol; 2009 Jun; 15(21):2595-601. PubMed ID: 19496188
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.
Kim SA; Kwak J; Nam HY; Chun SM; Lee BW; Lee HJ; Khang SK; Kim SW
Mod Pathol; 2013 May; 26(5):626-39. PubMed ID: 23328978
[TBL] [Abstract][Full Text] [Related]
6. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
Mazieres J; He B; You L; Xu Z; Lee AY; Mikami I; Reguart N; Rosell R; McCormick F; Jablons DM
Cancer Res; 2004 Jul; 64(14):4717-20. PubMed ID: 15256437
[TBL] [Abstract][Full Text] [Related]
7. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
[TBL] [Abstract][Full Text] [Related]
8. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.
Mitsui Y; Yasumoto H; Nagami T; Hiraki M; Arichi N; Ishikawa N; Araki A; Maruyama R; Tanaka Y; Dahiya R; Shiina H
Oncotarget; 2014 Apr; 5(8):2198-207. PubMed ID: 24755523
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.
Clément G; Guilleret I; He B; Yagui-Beltrán A; Lin YC; You L; Xu Z; Shi Y; Okamoto J; Benhattar J; Jablons D
Cancer Sci; 2008 Jan; 99(1):46-53. PubMed ID: 18005197
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
Huang L; Li MX; Wang L; Li BK; Chen GH; He LR; Xu L; Yuan YF
Tumour Biol; 2011 Feb; 32(1):233-40. PubMed ID: 21052890
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
Lin YC; You L; Xu Z; He B; Mikami I; Thung E; Chou J; Kuchenbecker K; Kim J; Raz D; Yang CT; Chen JK; Jablons DM
Biochem Biophys Res Commun; 2006 Mar; 341(2):635-40. PubMed ID: 16427602
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of WNT inhibitory factor-1 may be associated with the pathogenesis of multiple human tumors.
Zhou Y; Li Z; Ding Y; Zhang P; Wang J; Zhang J; Wang H
J Cancer Res Ther; 2018 Jun; 14(Supplement):S381-S387. PubMed ID: 29970693
[TBL] [Abstract][Full Text] [Related]
14. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
Asslaber M; Schauer S; Gogg-Kamerer M; Bernhart E; Quehenberger F; Haybaeck J
J Neuropathol Exp Neurol; 2017 Jan; 76(1):16-26. PubMed ID: 28040794
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
[TBL] [Abstract][Full Text] [Related]
16. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
Qi J; Zhu YQ; Luo J; Tao WH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
Tan M; Wu J; Cai Y
Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
20. Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.
Rubin EM; Guo Y; Tu K; Xie J; Zi X; Hoang BH
Mol Cancer Ther; 2010 Mar; 9(3):731-41. PubMed ID: 20197388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
